The fungus is not the diagnosis
Malassezia is a genus of lipid-dependent yeasts. On the human scalp the dominant species are usually M. restricta and M. globosa, and they are present on the majority of adults — including adults with no visible flaking at all. A shampoo that claims to “eliminate” the organism is claiming something that the microbiology does not support and, in most markets, something the regulator will not let you print.
What the organism does is hydrolyse sebum triglycerides with lipases and release free fatty acids, including oleic acid. In people whose stratum corneum is more permeable to oleic acid, that penetration produces subclinical irritation, a faster turnover of corneocytes and the visible clusters we call dandruff. In people whose barrier is intact, the same organism sits there without a symptom.
What actually moves the balance
Four levers matter more than the choice of active, and three of them are set by the rest of the formula.
- Sebum load. Higher sebum output means more substrate. Humidity, occlusive styling products, infrequent washing and hormonal shifts all raise it.
- Barrier condition. Repeated exposure to high-concentration anionic surfactants, hot water and mechanical irritation raises transepidermal water loss, and a compromised barrier responds to oleic acid more strongly.
- Surface pH. Scalp skin sits around pH 4.5–5.5. A strongly alkaline shampoo raises surface pH transiently and shifts the local environment; a formula buffered near skin pH is gentler and, for an ester-based active, also more stable.
- Residue. Cationic polymers, heavy oils and conditioning agents left on the scalp change both the substrate and the availability of any active you added.
Contact time is the constraint nobody puts on the label
A shampoo is on the scalp for one to three minutes, then diluted by at least an order of magnitude during rinse. A leave-on tonic stays for eight hours or more. Yet both are often formulated from the same minimum inhibitory concentration figure, measured in a well plate over 24–48 hours.
That figure tells you the intrinsic activity of the molecule. What decides your product is the same organism at 1% in a 12% surfactant system for 90 seconds, in hard water, at pH 5.8 — which is why the time-kill or suspension test at your use level is the one we scope first.
| Test | Answers | Does not answer |
|---|---|---|
| MIC / agar dilution | Intrinsic inhibitory concentration against a defined strain | Performance in a surfactant base, at your pH, in your contact window |
| Time-kill at use level | How much viability is lost in 1, 3 or 15 minutes at a real dose | Consumer-perceived benefit, or anything clinical |
| Finished-formula challenge | Whether the base itself suppresses the organism, with or without the active | Whether the effect survives rinsing and dilution |
Six questions that separate data from decoration
When a supplier sends a page of inhibition percentages, these are the questions that determine whether the number means anything for your project:
- Which strain, and is there an accession number? M. furfur and M. restricta are not interchangeable.
- Which method — agar dilution, broth microdilution, suspension?
- What is the endpoint: MIC50, MIC80 or MIC90?
- Was there a vehicle control (the base without the active)? Without it, the base may be doing the work.
- Was there a positive control, and what was it?
- Was the test run on the ingredient or on a finished formula?
Our own answers are on the technical page: MIC80 of 1.25 mg/mL against M. furfur by agar dilution, 89.66% inhibition at 1% after three minutes, and over 99.99% at 15–25 mg/mL over fifteen minutes against S. aureus, E. coli and C. albicans. All in-vitro, all on the ingredient, with the full methods in the dossier.
What this means for the formula
- Rinse-off: 1–3% of the ester, added to the cooled water phase, with a mild surfactant system so the product is not fighting the barrier it is meant to calm.
- Leave-on: 0.3–1.5%. Continuing exposure does the work; a higher dose mostly buys sensory intensity, not more inhibition.
- Claims: in the EU, anti-dandruff is a cosmetic function and needs substantiation; in the US, an anti-dandruff claim makes the product an OTC drug. Cooling and freshness are cosmetic claims in both.
This article is formulation background, not medical advice. It describes in-vitro microbiology and cosmetic formulation practice; it does not describe a treatment for a skin condition. Persistent or severe scalp symptoms belong with a clinician.